Filing Details

Accession Number:
0001415889-25-009017
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-26 16:03:00
Reporting Period:
2025-03-26
Filing Date:
2025-03-26
Accepted Time:
2025-03-26 16:03:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472012 Immunome Inc. IMNM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1167496 B Clay Siegall C/O Immunome, Inc.
18702 N. Creek Parkway, Suite 100
Bothell WA 98011
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-26 137,100 $7.29 806,736 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The weighted average purchase price for the transaction report was $7.29, and the range of prices were between $7.16 and $7.40, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.